BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7450275)

  • 1. The export of a trypsin inhibitor from Ehrlich ascites cells that does not inhibit a trypsin-like enzyme on the surface of these cells.
    Steven FS; Griffin MM; Itzhaki S; Al-Habib A
    Biochem Soc Trans; 1980 Oct; 8(5):650-1. PubMed ID: 7450275
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition properties of Sepharose-bound trypsin and a protease on the surface of Ehrlich ascites tumour cells.
    Steven FS; Griffin MM; Itzhaki GS; Al-Habib A
    Biochim Biophys Acta; 1981 Aug; 660(2):333-40. PubMed ID: 6269636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the presence of a trypsin inhibitor within rabbit and mouse tumour cells.
    Steven FS; Podrazky V; Itzhaki S
    Biochim Biophys Acta; 1977 Jul; 483(1):211-4. PubMed ID: 880306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the zymogen of collagenase by Ehrlich-ascites-tumour-cell-surface trypsin-like enzyme.
    Steven FS; Griffin MM; Itzhaki S
    Biochem Soc Trans; 1980 Oct; 8(5):647-8. PubMed ID: 6256244
    [No Abstract]   [Full Text] [Related]  

  • 5. A trypsin-like neutral protease on Ehrlich ascites cell surfaces: its role in the activation of tumour-cell zymogen of collagenase.
    Steven FS; Griffin MM; Itzhaki S; Al-Habib A
    Br J Cancer; 1980 Nov; 42(5):712-21. PubMed ID: 6257267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of plasminogen activator and trypsin inhibitor in gastric cancer, ulcer and experimental tumor].
    Tsuchiya T
    Nihon Geka Hokan; 1969 Sep; 38(5):760-76. PubMed ID: 5389514
    [No Abstract]   [Full Text] [Related]  

  • 7. Displacement of trypsin from the tumour-cell inhibitor-trypsin complex by exchange, by using enzymes with blocked active centres [proceedings].
    Steven F; Podrazký V
    Biochem Soc Trans; 1978; 6(4):765-7. PubMed ID: 710711
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of cell-surface neutral protease of Ehrlich ascites tumor cells by potassium p-(3,3-dimethyl-1-triazeno) benzoate.
    Steven FS; Brown BS; Hulley TP; Itzhaki S; Giraldi T; Lassiani L
    Biochem Int; 1985 Aug; 11(2):153-60. PubMed ID: 3902023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Naphthylamidase activity of the cell surface of Ehrlich ascites cells. Reversible control of enzyme activity by metal ions and thiols.
    Short AK; Steven FS; Griffin MM; Itzhaki S
    Br J Cancer; 1981 Nov; 44(5):709-16. PubMed ID: 6797455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition kinetics of a trypsin-like neutral proteinase on the surface of Ehrlich ascites-tumour cells.
    Steven FS; Griffin MM; Itzhaki S
    Biochem Soc Trans; 1981 Feb; 9(1):146-7. PubMed ID: 7011870
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of free and bound trypsin-like enzymes.
    Steven FS; Griffin MM; Itzhaki S
    Eur J Biochem; 1982 Aug; 126(2):311-8. PubMed ID: 7128592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings: Independent responses of different binding sites on ehrlich ascites tumour cells to trypsin and trypsin inhibitor.
    Whur P; Payne NE; Koppel H
    Br J Cancer; 1974 Jan; 29(1):96. PubMed ID: 4820961
    [No Abstract]   [Full Text] [Related]  

  • 13. Release of malignancy-related fucopeptides from ascites tumour cells in association with membrane vesicles.
    Walsh E; Smyth H; McGuinness M
    Eur J Cancer Clin Oncol; 1987 Dec; 23(12):1851-7. PubMed ID: 3436349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous and endogenous protease inhibitors in the gut of the fall armyworm larvae, Spodoptera frugiperda.
    Lwalaba D; Weidlich S; Hoffmann KH; Woodring J
    Arch Insect Biochem Physiol; 2010 Jun; 74(2):114-26. PubMed ID: 20513059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of a trypsin-dependent neutral protease and its inhibitor found in tumour cells. Analysis of complex kinetic data involved in a thiol-disulphide exchange mechanism.
    Steven FS; Podrazký V; Itzhaki S
    Biochim Biophys Acta; 1978 May; 524(1):170-82. PubMed ID: 656442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liberation of cell surface material by the insoluble trypsin derivative.
    Kocemba-Sliwowska U; Kawiak J
    Acta Biochim Pol; 1973; 20(2):113-8. PubMed ID: 4715517
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of protease and protease inhibitors on the adhesion of Ehrlich ascites tumour cells to plastic.
    Whur P; Payne NE; Koppel H
    Exp Cell Res; 1974 Jun; 86(2):422-5. PubMed ID: 4842908
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in growth and adhesion of Ehrlich ascites tumour cells coated with trypsin inhibitor (soybean).
    Whur P; Robson RT; Payne NE
    Br J Cancer; 1973 Jul; 28(1):80. PubMed ID: 4737503
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: Autoradiography of Ehrlich ascites tumours treated with soybean trypsin inhibitor in vivo.
    Whur P; Koppel H; Weatherhead B
    Br J Cancer; 1975 Aug; 32(2):247-8. PubMed ID: 1212374
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence for an enzyme which cleaves the guanidinobenzoate moiety from active-site titrants specifically designed to inhibit and quantify trypsin.
    Steven FS; Al-Ahmad RK
    Eur J Biochem; 1983 Feb; 130(2):335-9. PubMed ID: 6825699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.